Page last updated: 2024-10-24

carbamazepine and Genetic Diseases, Inborn

carbamazepine has been researched along with Genetic Diseases, Inborn in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Genetic Diseases, Inborn: Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scheffer, IE1
Bhatia, KP1
Lopes-Cendes, I1
Fish, DR1
Marsden, CD1
Andermann, F1
Andermann, E1
Desbiens, R1
Cendes, F1
Manson, JI1

Reviews

1 review available for carbamazepine and Genetic Diseases, Inborn

ArticleYear
Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder.
    Lancet (London, England), 1994, Feb-26, Volume: 343, Issue:8896

    Topics: Adolescent; Carbamazepine; Diagnosis, Differential; Diagnostic Errors; Epilepsy, Frontal Lobe; Femal

1994